Our corporation was founded with joint venture by prominent Japanese CRO,SRD Co., Ltd., and a China based CRO,ClinMax (Shanghai). With close relationship between Japan and China, either country’s market is becoming more and more important to the other. It’s particularly true for medical products. On one hand, China has huge demand for Japanese innovative medical products; on the other hand, China’s ever changing regulatory environment has prevented many innovative products from entering China. For those Japanese sponsors who want to enter China market, the needs for help on best/practical regulatory paths and management of local challenges are essential! And SRD ClinMax Co. was founded just to meet such needs, particularly for Japanese clients who want their products to China and vice versa. The combination of successful experiences and local influences of SRD Co.(in Japan) and ClinMax (in China) puts SRD ClinMax in a unique position for helping pharmaceutical and medical device companies who want to expand market across Pacific Ocean.